Evolus Inc. today announced an exclusive licensing and distribution agreement with Swiss pharmaceutical company IBSA to develop and commercialize Profhilo in the U.S.
Profhilo, launched...
RxSight Inc. yesterday announced preliminary second quarter results and updated its 2026 sales guidance.
The Aliso Viejo-based cataract lens maker expects second quarter revenue between...